Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Apr 05, 2016 $148.03 $148.03 $148.03 $148.03 1 718 949
Apr 04, 2016 $147.10 $147.10 $147.10 $147.10 1 989 817
Apr 01, 2016 $142.94 $142.94 $142.94 $142.94 2 015 254
Mar 31, 2016 $139.22 $139.22 $139.22 $139.22 1 823 623
Mar 30, 2016 $135.25 $135.25 $135.25 $135.25 1 017 867
Mar 29, 2016 $134.54 $134.54 $134.54 $134.54 1 165 200
Mar 28, 2016 $132.50 $132.50 $132.50 $132.50 1 294 500
Mar 24, 2016 $133.19 $133.19 $133.19 $133.19 1 218 600
Mar 23, 2016 $133.63 $133.63 $133.63 $133.63 2 325 100
Mar 22, 2016 $135.71 $135.71 $135.71 $135.71 2 197 100
Mar 21, 2016 $131.06 $131.06 $131.06 $131.06 1 498 800
Mar 18, 2016 $128.45 $128.45 $128.45 $128.45 2 593 700
Mar 17, 2016 $127.91 $127.91 $127.91 $127.91 2 832 900
Mar 16, 2016 $130.84 $130.84 $130.84 $130.84 1 489 000
Mar 15, 2016 $134.44 $134.44 $134.44 $134.44 2 163 000
Mar 14, 2016 $134.50 $134.50 $134.50 $134.50 1 638 800
Mar 11, 2016 $139.27 $139.27 $139.27 $139.27 1 692 800
Mar 10, 2016 $136.76 $136.76 $136.76 $136.76 1 803 000
Mar 09, 2016 $140.52 $140.52 $140.52 $140.52 2 013 700
Mar 08, 2016 $141.03 $141.03 $141.03 $141.03 1 948 100
Mar 07, 2016 $149.60 $149.60 $149.60 $149.60 1 107 500
Mar 04, 2016 $144.46 $144.46 $144.46 $144.46 1 349 800
Mar 03, 2016 $145.85 $145.85 $145.85 $145.85 1 328 800
Mar 02, 2016 $151.59 $151.59 $151.59 $151.59 1 871 400
Mar 01, 2016 $150.83 $150.83 $150.83 $150.83 2 193 900
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT